Related by context. Frequent words. (Click for all words.) 78 Annual Meeting Date 75 Option Grants 74 Share Repurchases 73 Shareholder Vote 72 3rd Quarter Results 72 Dividend Increase 72 Q2 Loss Narrows 71 2nd Quarter Results 71 Previously Announced 71 Upcoming Conferences 71 Stock Buyback 71 Share Repurchase Plan 71 Reaffirms Guidance 71 CFO Resigns 71 Stockholders Approve 70 Stock Repurchase Plan 70 Complete Merger 70 Shareholder Letter 70 Provides Guidance 70 1st Quarter Results 70 Extends Tender Offer 70 Shareholder Approval 70 Q3 Loss Narrows 70 Vertex Pharmaceuticals Announces 70 Record Second Quarter 70 Q1 Loss Narrows 70 Special Shareholder Meeting 70 Updates Guidance 69 Holds Annual Meeting 69 Record Third Quarter 69 Q2 Loss Widens 69 Share Buyback 69 Hold Fourth Quarter 69 Hostile Bid 68 Buyout Offer 68 Revenues Decline 68 Stockholders Vote 68 Succession Plan 68 #.#/Share [002] 68 Lowers Guidance 68 Q4 Loss Narrows 68 Shelf Registration Statement 68 Q3 Loss Widens 68 Declares Quarterly Dividends 68 Regains Compliance 68 Fiscal Third Quarter 68 Q4 Loss Widens 68 1st Quarter Earnings 68 Patient Enrollment 67 Two Investor Conferences 67 Dividend Payment 67 Announces Organizational Changes 67 Q1 Loss Widens 67 Smallpox Vaccine 67 Merger Proposal 67 Files Annual Report 67 Q3 Profit Surges 67 Boosts Dividend 67 Prostate Cancer Patients 67 Stockholder Rights Plan 67 Webcast Annual Meeting 67 Announces Definitive Agreement 67 Forecast Quick Facts 67 Q4 Profit Surges 67 Announces Intent 67 Updates Shareholders 67 Schedules Fiscal 67 Issues Guidance 67 Provides Preliminary 67 Posts Wider Loss 66 Cervical Cancer Vaccine 66 Shareholders Approve Merger 66 End Earnings Release 66 Extends Offer 66 .# Per Share 66 Shareholder Update 66 Raises Dividend 66 Guidance Quick Facts 66 Upcoming Investor Conference 66 Analyst Upgrade 66 Stock Repurchase 66 Shareholders Approve 66 Net Loss Narrows 66 Organizational Structure 66 4th Quarter Earnings 66 Announces Intention 66 Increases Dividend 66 Stock Repurchase Program 66 Declares Common 66 Announces Initiation 66 Preliminary Fourth Quarter 66 Clinical Trial Results 65 Releases Third Quarter 65 Shareholders Elect 65 Discuss Third Quarter 65 Declares Regular Quarterly Dividend 65 Discuss Fourth Quarter 65 Cholesterol Drug 65 Upcoming Investor Conferences 65 M d yyyy 65 Declares Monthly Dividend